Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Sculpher

Showing results (91-100 of 174) with videos related to

Pageof 18
Sort By:
Health Economics|March 1, 2005
Probabilistic sensitivity analysis for NICE technology assessment: not an optional extraKarl Claxton, Mark Sculpher, Chris McCabe, et al.
BMJ (Clinical Research Ed.)|November 2, 2002
Incidence of fires and related injuries after giving out free smoke alarms: cluster randomised controlled trialCarolyn DiGuiseppi, Ian Roberts, Angie Wade, et al.
BMJ Global Health|April 18, 2018
Supporting the development of a health benefits package in MalawiJessica Ochalek, Paul Revill, Gerald Manthalu, et al.
BMC Medical Research Methodology|October 8, 2016
Methods for network meta-analysis of continuous outcomes using individual patient data: a case study in acupuncture for chronic painPedro Saramago, Beth Woods, Helen Weatherly, et al.
Pharmacoeconomics|February 6, 2010
Alitretinoin for severe chronic hand eczema: a NICE single technology appraisalMark Rodgers, Susan Griffin, Mike Paulden, et al.
Artificial Organs|October 31, 2008
Economic evaluation of coronary artery bypass grafting surgery with and without cardiopulmonary bypass: cost-effectiveness and quality-adjusted life years in a randomized controlled trialSharif Al-Ruzzeh, David Epstein, Shane George, et al.
Pharmacoeconomics|January 31, 2012
Golimumab for the treatment of psoriatic arthritis: a NICE single technology appraisalHuiqin Yang, Dawn Craig, David Epstein, et al.
Health Technology Assessment (Winchester, England)|March 18, 2016
The Protease Inhibitor Monotherapy Versus Ongoing Triple Therapy (PIVOT) trial: a randomised controlled trial of a protease inhibitor monotherapy strategy for long-term management of human immunodeficiency virus infectionNicholas I Paton, Wolfgang Stöhr, Lars Oddershede, et al.
Clinical Genitourinary Cancer|March 8, 2020
Effects of Bladder Cancer on UK Healthcare Costs and Patient Health-Related Quality of Life: Evidence From the BOXIT TrialEdward Cox, Pedro Saramago, John Kelly, et al.
Pharmacoeconomics|March 12, 2016
Cost Effectiveness of Protease Inhibitor Monotherapy Versus Standard Triple Therapy in the Long-Term Management of HIV Patients: Analysis Using Evidence from the PIVOT TrialLars Oddershede, Simon Walker, Wolfgang Stöhr, et al.
Pageof 18

Showing results (91-100 of 174) with videos related to

Sort By:
Pageof 18
Health Economics|March 1, 2005
Probabilistic sensitivity analysis for NICE technology assessment: not an optional extraKarl Claxton, Mark Sculpher, Chris McCabe, et al.
BMJ (Clinical Research Ed.)|November 2, 2002
Incidence of fires and related injuries after giving out free smoke alarms: cluster randomised controlled trialCarolyn DiGuiseppi, Ian Roberts, Angie Wade, et al.
BMJ Global Health|April 18, 2018
Supporting the development of a health benefits package in MalawiJessica Ochalek, Paul Revill, Gerald Manthalu, et al.
BMC Medical Research Methodology|October 8, 2016
Methods for network meta-analysis of continuous outcomes using individual patient data: a case study in acupuncture for chronic painPedro Saramago, Beth Woods, Helen Weatherly, et al.
Pharmacoeconomics|February 6, 2010
Alitretinoin for severe chronic hand eczema: a NICE single technology appraisalMark Rodgers, Susan Griffin, Mike Paulden, et al.
Artificial Organs|October 31, 2008
Economic evaluation of coronary artery bypass grafting surgery with and without cardiopulmonary bypass: cost-effectiveness and quality-adjusted life years in a randomized controlled trialSharif Al-Ruzzeh, David Epstein, Shane George, et al.
Pharmacoeconomics|January 31, 2012
Golimumab for the treatment of psoriatic arthritis: a NICE single technology appraisalHuiqin Yang, Dawn Craig, David Epstein, et al.
Health Technology Assessment (Winchester, England)|March 18, 2016
The Protease Inhibitor Monotherapy Versus Ongoing Triple Therapy (PIVOT) trial: a randomised controlled trial of a protease inhibitor monotherapy strategy for long-term management of human immunodeficiency virus infectionNicholas I Paton, Wolfgang Stöhr, Lars Oddershede, et al.
Clinical Genitourinary Cancer|March 8, 2020
Effects of Bladder Cancer on UK Healthcare Costs and Patient Health-Related Quality of Life: Evidence From the BOXIT TrialEdward Cox, Pedro Saramago, John Kelly, et al.
Pharmacoeconomics|March 12, 2016
Cost Effectiveness of Protease Inhibitor Monotherapy Versus Standard Triple Therapy in the Long-Term Management of HIV Patients: Analysis Using Evidence from the PIVOT TrialLars Oddershede, Simon Walker, Wolfgang Stöhr, et al.
Pageof 18